Unable to load price data. Sorry.

¯\_(ツ)_/¯

Dyax Corp. (NASDAQ:DYAX.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:DYAX.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

gringo33339 (< 20)
Submitted April 26, 2013

Buying opportunity today for this stock which will benefit greatly if LLY sees success in its Ramu pipeline drug candidate.

majakblue (< 20)
Submitted April 14, 2007

Yeah, yeah, yeah, lets see if any of their candidates get past large scale phase III trials. Lets see if the patients have kidneys and liver left afterwards.

NASDAQ:DYAX.DL VS S&P 500 (SPY)

NASDAQ:DYAX.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about DYAX.DL.

No one has written a Pitch for DYAX.DL stock yet. Tell us why you think DYAX.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in DYAX.DL.

No players have picked DYAX.DL yet. Tell us why you think DYAX.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for DYAX.DL.